Surgalign to Exhibit at the Society for Minimally Invasive Spine Surgery (“SMISS”) Annual Forum and the North American Spine Society (“NASS”) 2022 Annual Meeting
September 08 2022 - 2:00PM
Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical
technology company focused on elevating the standard of care by
driving the evolution of digital health, today announced two
upcoming industry events it will be participating in and showcasing
many of its latest spine and technology innovations.
The Society for Minimally Invasive Spine Surgery
(“SMISS”) will be hosting its Annual Forum on September 29
– October 1, 2022, at the Bellagio in Las Vegas, NV. This three-day
event brings together the international community of spine
surgeons, orthopaedic surgeons, and neurosurgeons in an open forum
focused entirely on minimally invasive spine surgery. Surgalign
will be exhibiting (Booth #301) many of its latest
product innovations, including its Coflex® Interlaminar
Stabilization Device, CoFix™ Posterior MIS Fusion System, and
CervAlign® Anterior Cervical Plate System, along with its
biomaterials portfolio and TETRAfuse® 3D technology. The
Company will also be participating in the MISS Track Cadaveric Lab
on September 29th and for the first time at any industry event,
will be featuring its HOLO Portal™ Surgical Guidance System with
live, hands-on demonstrations.
The North American Spine Society (“NASS”) will
be hosting its 37th Annual Meeting on October 12-15, 2022, at
McCormick Place-West Building in Chicago, IL. Founded in 1985, NASS
is a global multidisciplinary medical organization for health care
professionals who specialize in spinal care and are dedicated to
fostering the highest quality, ethical, value-based and
evidence-based spinal care through education, research and
advocacy. This four-day event will include educational courses,
symposiums, webinars and various education programs to foster
better patient outcomes in spinal care and will feature hands-on
demonstrations from leading spine surgeons around the globe.
Surgalign will have on display (Booth #4841) its
Coflex Interlaminar Stabilization Device, CoFix Posterior MIS
Fusion System, CervAlign Anterior Cervical Plate System, and many
of its biomaterials products and TETRAfuse 3D technology. The
Company will also be showcasing its HOLO Portal Surgical Guidance
System in its booth.
“We’ve made great strides over the past year developing and
bringing to market, new and differentiated products for our
customers that are designed to improve patient outcomes, and we
look forward to showcasing many of our innovations at SMISS and
NASS in the coming weeks,” stated Terry Rich, President and CEO of
Surgalign. “We’re especially excited to debut the HOLO Portal
system at industry events as we move forward in our
commercialization initiatives and expand our reach.”
About Surgalign Holdings, Inc.Surgalign
Holdings, Inc. is a global medical technology company committed to
the promise of digital health to drive transformation across the
surgical landscape. Uniquely aligned and resourced to advance the
standard of care, the company is building technologies physicians
and other health providers will look to for what is truly possible
for their patients. Surgalign is focused on developing solutions
that predictably deliver superior clinical and economic outcomes.
Surgalign markets products throughout the United States and in
approximately 50 countries worldwide through an expanding network
of top independent distributors. Surgalign is headquartered in
Deerfield, IL, with commercial, innovation and design centers in
San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany.
Learn more at www.surgalign.com and connect on LinkedIn and
Twitter.
Forward Looking StatementThis press release
contains forward-looking statements based on management’s current
expectations, estimates and projections about our products,
company, and industry, our management's beliefs, and certain
assumptions made by our management. Words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
and other variations of such words and similar expressions are
intended to identify such forward-looking statements. These
statements are not guarantees of future performance and are subject
to risks and uncertainties, including the risks described in our
public filings with the U.S. Securities and Exchange Commission
(SEC). Our actual results may differ materially from the
anticipated results reflected in these forward-looking statements.
Copies of the company's SEC filings may be obtained by contacting
the company or the SEC or by visiting Surgalign's website
at www.surgalign.com or the SEC's website
at www.sec.gov.
Investor and Media Contact: |
Surgalign Contact: |
Glenn Wiener |
Kristine Simmons |
E: gwiener@gwcco.com |
E: ksimmons@surgalign.com |
T: +1 917 887 8434 |
T: +1 619 206 4648 |
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Sep 2023 to Sep 2024